Abacus Health Products
Woonsocket
About Abacus Health Products
Abacus Health Products develops, markets and sells CBDCLINIC™ and CBDMEDIC™. The first family of FDA-registered, over-the-counter (OTC) line of topical pain relieving products infused with cannabidiol (CBD), which is a medicinal, non-psychoactive extract of cannabis. Abacus’ products utilize a combination of CBD and terpenes with varying concentrations of FDA approved analgesics to ameliorate mild - severe pain symptoms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $25.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (May 2019)
- Ticker: otcqb:ABAHF
- Website: abacushp.com
- Phone: (401) 709-9593
Industries & Categories
Biotechnology, Health Care, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/abacus-health-products-2216609 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.